Adaptive Biotechnologies Corp’s recent filing unveils that its Chief Commercial Ofc Imm Med BENZENO SHARON unloaded Company’s shares for reported $5.22 million on Nov 21 ’25. In the deal valued at $16.91 per share,308,477 shares were sold. As a result of this transaction, BENZENO SHARON now holds 296,791 shares worth roughly $6.07 million.
Then, BENZENO SHARON sold 297,925 shares, generating $4,927,680 in total proceeds. Upon selling the shares at $16.54, the Chief Commercial Ofc Imm Med now owns 296,791 shares.
Before that, SHARON BENZENO bought 308,837 shares. Adaptive Biotechnologies Corp shares valued at $5,040,220 were divested by the Officer at a price of $16.32 per share.
Guggenheim initiated its Adaptive Biotechnologies Corp [ADPT] rating to a Buy in a research note published on September 30, 2025; the price target was $20. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Goldman also remained covering ADPT and has increased its forecast on March 21, 2025 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of ADPT
On Monday, Adaptive Biotechnologies Corp [NASDAQ:ADPT] saw its stock jump 9.94% to $20.46. Over the last five days, the stock has gained 49.23%. Adaptive Biotechnologies Corp shares have risen nearly 362.90% since the year began. Nevertheless, the stocks have risen 241.28% over the past one year. While a 52-week high of $18.98 was reached on 11/24/25, a 52-week low of $4.29 was recorded on 01/02/25.
Levels Of Support And Resistance For ADPT Stock
The 24-hour chart illustrates a support level at 19.02, which if violated will result in even more drops to 17.59. On the upside, there is a resistance level at 21.27. A further resistance level may holdings at 22.09.
How much short interest is there in Adaptive Biotechnologies Corp?
A steep rise in short interest was recorded in Adaptive Biotechnologies Corp stocks on 2025-10-31, dropping by -0.58 million shares to a total of 9.01 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 9.59 million shares. There was a decline of -6.42%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $15 price target.
